Imidex to Sell Company at RSNA in Chicago, Featuring Leading FDA 510(k) Cleared AI Technology for Lung Nodule and Mass Detection

Imidex’s Technology is a Front-End Patient Acquisition Tool for Healthcare Providers Targeting Early Lung Cancer Detection, Achieving 83% Sensitivity in Identifying Lung Nodules in Chest X-rays. DENVER, Nov. 29, 2024 /PRNewswire/ — Imidex, a leader in developing artificial intelligence…